Heart failure guidelines for India: Update 2017
Heart failure (HF) is a major health problem in India with a postadmission mortality of 20%–30%. Medication adherence ranges from 25% to 50%, and the tolerance of guideline-based medication is low for Indian patients. We took out guidelines on HF in 2015, and this update covers the changes which hav...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Journal of the Practice of Cardiovascular Sciences |
Subjects: | |
Online Access: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=3;spage=133;epage=138;aulast=Seth |
id |
doaj-f101cfe29c874cec84b40e8d5ce3f492 |
---|---|
record_format |
Article |
spelling |
doaj-f101cfe29c874cec84b40e8d5ce3f4922020-11-24T23:25:47ZengWolters Kluwer Medknow PublicationsJournal of the Practice of Cardiovascular Sciences2395-54142454-28302017-01-013313313810.4103/jpcs.jpcs_1_18Heart failure guidelines for India: Update 2017Sandeep SethS RamakrishnanNeeraj ParekhG KarthikeyanSandeep SinghGautam SharmaHeart failure (HF) is a major health problem in India with a postadmission mortality of 20%–30%. Medication adherence ranges from 25% to 50%, and the tolerance of guideline-based medication is low for Indian patients. We took out guidelines on HF in 2015, and this update covers the changes which have occurred in HF management in the past 2 years. As a number of new drugs such as angiotensin receptor-neprilysin inhibitor and ivabradine have been approved for use in India, devices such as implantable cardioverter-defibrillators and cardiac resynchronization therapy are becoming more accessible and more left ventricular assist devices and transplants are being done in India, there is need for clear guidelines for the use of each which are practical for India.http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=3;spage=133;epage=138;aulast=Seth2017heart failure guidelinesIndia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sandeep Seth S Ramakrishnan Neeraj Parekh G Karthikeyan Sandeep Singh Gautam Sharma |
spellingShingle |
Sandeep Seth S Ramakrishnan Neeraj Parekh G Karthikeyan Sandeep Singh Gautam Sharma Heart failure guidelines for India: Update 2017 Journal of the Practice of Cardiovascular Sciences 2017 heart failure guidelines India |
author_facet |
Sandeep Seth S Ramakrishnan Neeraj Parekh G Karthikeyan Sandeep Singh Gautam Sharma |
author_sort |
Sandeep Seth |
title |
Heart failure guidelines for India: Update 2017 |
title_short |
Heart failure guidelines for India: Update 2017 |
title_full |
Heart failure guidelines for India: Update 2017 |
title_fullStr |
Heart failure guidelines for India: Update 2017 |
title_full_unstemmed |
Heart failure guidelines for India: Update 2017 |
title_sort |
heart failure guidelines for india: update 2017 |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of the Practice of Cardiovascular Sciences |
issn |
2395-5414 2454-2830 |
publishDate |
2017-01-01 |
description |
Heart failure (HF) is a major health problem in India with a postadmission mortality of 20%–30%. Medication adherence ranges from 25% to 50%, and the tolerance of guideline-based medication is low for Indian patients. We took out guidelines on HF in 2015, and this update covers the changes which have occurred in HF management in the past 2 years. As a number of new drugs such as angiotensin receptor-neprilysin inhibitor and ivabradine have been approved for use in India, devices such as implantable cardioverter-defibrillators and cardiac resynchronization therapy are becoming more accessible and more left ventricular assist devices and transplants are being done in India, there is need for clear guidelines for the use of each which are practical for India. |
topic |
2017 heart failure guidelines India |
url |
http://www.j-pcs.org/article.asp?issn=2395-5414;year=2017;volume=3;issue=3;spage=133;epage=138;aulast=Seth |
work_keys_str_mv |
AT sandeepseth heartfailureguidelinesforindiaupdate2017 AT sramakrishnan heartfailureguidelinesforindiaupdate2017 AT neerajparekh heartfailureguidelinesforindiaupdate2017 AT gkarthikeyan heartfailureguidelinesforindiaupdate2017 AT sandeepsingh heartfailureguidelinesforindiaupdate2017 AT gautamsharma heartfailureguidelinesforindiaupdate2017 |
_version_ |
1725556062810013696 |